Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

5 evidence items · page 1 / 1

15.4 %Pretreatment HIV drug resistance (PDR) frequency was 15.4% in Mali.

MaliVIH/sidapublished 2018Journal of Antimicrobial ChemotherapyOpenAlexdocument of 9 observationsDOI 10.1093/jac/dky443

20 %La prévalence de la neuropathie chez les personnes vivant avec le VIH au Malawi était de 20 % en 2014.

MaliVIH/sidaobserved 2014HAL · Unilimdocument of 747 observations

1.4 %The HIV prevalence rate is 1.4% in Mali.

MaliVIH/sidaHAL · Unilimdocument of 97 observations

8 %HIV-attributed mortality among infants and children was 8% in Mali (13 [8%] of 168).

MaliVIH/sidaobserved Dec 3, 2016 to Dec 31, 2024published 2026The lancet. HIVPubMeddocument of 23 observations

13.1 %Microsporidia were detected in stools from 8 of 61 HIV-seropositive adult patients in Mali, representing a prevalence of 13.1%.

Malimicrosporidia · VIH/sidapublished 2002Journal of clinical microbiologyeurope_pmcdocument of 3 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.